一家知名药企作为有限合伙人(LP)参与的产业投资基金,本该投向前沿创新药项目,资金却诡异地流入了二级市场,最终大举买入了该药企自己的股票。这种看似荒谬的剧情,正在以更隐蔽的方式在市场中上演。某季报显示:一家上市CXO企业前十大股东中,出现了一家刚成立不久的产业投资基金。该基金的主要出资人,正是这家CXO企业自身。调查发现:这支号称专注于早期创新药投资的基金,竟有超过1/3的资金流向了二级市场,而且...
Source Link一家知名药企作为有限合伙人(LP)参与的产业投资基金,本该投向前沿创新药项目,资金却诡异地流入了二级市场,最终大举买入了该药企自己的股票。这种看似荒谬的剧情,正在以更隐蔽的方式在市场中上演。某季报显示:一家上市CXO企业前十大股东中,出现了一家刚成立不久的产业投资基金。该基金的主要出资人,正是这家CXO企业自身。调查发现:这支号称专注于早期创新药投资的基金,竟有超过1/3的资金流向了二级市场,而且...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.